Mark Allen

Mark Allen

Company: Elevian

Job title: Co-Founder & CEO


Dr. Allen is Co-Founder and CEO of Elevian, a preclinical stage biotech developing therapeutics that target aging.  Dr. Allen is a serial entrepreneur and executive, with experience leading organizations from inception to profitable growth to successful exit. Most recently, Dr. Allen was the Founder & CEO of Corticon, sold to Progress (NASD: PRGS), a leading rules engine powering automated decision-making in healthcare, retail, government and financial services. A member of YPO since 2009 and officer of YPO SF Gold, Dr. Allen has a BS in Applied Physics from Columbia University and an MD from UCLA.

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.